Ocular Adverse Effects of Psychotropic Drugs: A Clinical Study of 20 Cases (2023–2025)
Authors/Creators
- 1. Department of Ophthalmology, Specialty Hospital of Rabat, Mohammed V University – Faculty of Medicine and Pharmacy, Rabat, Morocco
- 2. Department of Ophthalmology, Hassan II Military Hospital, Faculty of Medicine and Pharmacy, Ibn Zohr University, Laâyoune, Morocco
Description
Abstract:
Purpose: To analyze the ocular adverse effects induced by psychotropic medications and describe their mechanisms according to drug classes.
Methods: A retrospective descriptive study involving 20 patients followed between January 2023 and June 2025 for ocular manifestations secondary to psychotropic therapy.
Results: The mean age was 49 years (18–72), with a female predominance (60%). Neuroleptics accounted for 40% of prescriptions, antidepressants for 30%, anxiolytics for 20%, and mood stabilizers for 10%. The most frequent ocular effects were dry eye (45%), accommodative disorders (25%), ocular hypertension or acute glaucoma (15%), corneal deposits (10%), and retinal changes (5%).
Conclusion: Psychotropic drugs may cause a wide range of ocular side effects. Early detection and collaboration between psychiatrists and ophthalmologists are essential to prevent visual complications.
Files
8.pdf
Files
(371.8 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:fa6735c641b7c03bb66e99e104bbfa3c
|
371.8 kB | Preview Download |